SCHEMBL15957883

SCHEMBL15957883

Cc1cc(C(O)(C(F)(F)F)C(F)(F)F)c(C)cc1C(O)(C(F)(F)F)C(F)(F)F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.50
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
MAPK1 P28482 2/20 0.42
HSD17B10 Q99714 2/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
PGK1 P00558 1/20 0.40
PGK2 P07205 1/20 0.40
KDM4E B2RXH2 2/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
AR P10275 4/20 0.39
NR1H2 P55055 4/20 0.37
NR1H3 Q13133 4/20 0.37
MLYCD O95822 1/20 0.36
CA2 P00918 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15834432 0.92 SMN1; SMN2 (0.48) SMN1; SMN2MEN1KMT2AMAPK1HSD17B10
SCHEMBL15958203 0.90 SMN1; SMN2 (0.50) SMN1; SMN2MEN1KMT2AMAPK1HSD17B10
SCHEMBL15957621 0.89 MAPK1 (0.43) SMN1; SMN2MEN1KMT2AMAPK1HSD17B10
SCHEMBL15957626 0.89 SMN1; SMN2 (0.43) SMN1; SMN2MEN1KMT2AMAPK1HSD17B10
SCHEMBL15957614 0.87 SMN1; SMN2 (0.55) SMN1; SMN2MEN1KMT2AMAPK1HSD17B10
SCHEMBL15957877 0.84 SMN1; SMN2 (0.43) SMN1; SMN2MEN1KMT2AMAPK1HSD17B10
SCHEMBL17287107 0.84 SMN1; SMN2 (0.40) SMN1; SMN2MEN1KMT2AMAPK1HSD17B10
SCHEMBL15957878 0.83 SMN1; SMN2 (0.55) SMN1; SMN2MEN1KMT2AMAPK1HSD17B10
SCHEMBL15957875 0.82 RXRB (0.41) SMN1; SMN2MEN1KMT2AHSD17B10ALOX15
SCHEMBL15957891 0.81 SMN1; SMN2 (0.44) SMN1; SMN2MEN1KMT2AMAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809451-B2 Fluorinated dicarboxylic acid derivative and polymer obtained therefrom CENTRAL GLASS COMPANY, LIMITED (JP) 2014-08-19 US disclosed
US-20110301305-A1 Fluorinated Dicarboxylic Acid Derivative and Polymer Obtained Therefrom CENTRAL GLASS COMPANY, LIMITED (JP) 2011-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110301305-A1 Fluorinated Dicarboxylic Acid Derivative and Polymer Obtained Therefrom MCCC2, AFF2, F13A1 SMN1; SMN2 3546/4885MEN1 1359/4885KMT2A 326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.